| 3-(((2R)-Oxolan-2-yl)methyl)-2-sulfanylidene-7H-purin-6-one | IC50 | 9.0 [1], 12.0 [2], 56.0 [3], 1000.0 [4] |
| 7-Benzyloxy-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamine | IC50 | 84.0 [1], 110.0 [2], 5000.0 [3] |
| 5-(2,4,5-Trichlorophenoxy)pyridin-2-amine | IC50 | 320.0 [1], 360.0 [2], 840.0 [3], 1700000.0 [4] |
| Quercetin | IC50 | 1150.0 [1], 1270.0 [2], 3100.0 [3] |
| Hydralazine | IC50 | 900.0 [1], 2360.0 [2] |
| 5-Fluorotryptamine | IC50 | 200.0 [1], 790.0 [2], 940.0 [3] |
| (7-Methoxy-4-methyl-quinazolin-2-yl)-guanidine | IC50 | 44.0 [1], 90.0 [2], 93100.0 [3] |
| 4-(5-Fluoro-1H-indol-3-yl)butylamine | IC50 | 8.0 [1], 12.0 [2], 15.0 [3] |
| N-Benzyl-3-(5-fluoro-1H-indol-3-yl)propan-1-amine | IC50 | 13.0 [1], 30.0 [2] |
| 5-(5-Fluoro-1H-indol-3-yl)pentan-1-amine | IC50 | 5.0 [1], 8.0 [2] |
| 4-(5-Fluoro-1H-indol-3-yl)butanamide | IC50 | 18.0 [1] |
| L-Tryptophan benzyl ester | IC50 | 110.0 [1], 200.0 [2], 13000.0 [3] |
| 2-[(3R)-1-(2,3-Dihydro-1H-imidazol-2-ylmethyl)pyrrolidin-3-yl]-6-fluoro-1H-benzimidazole | IC50 | 50.0 [1], 120.0 [2], 313600.0 [3] |
| Metoclopramide | IC50 | 350.0 [1], 5000.0 [2] |
| Propylthiouracil | IC50 | 2810.0 [1], 5700.0 [2] |
| Mefenamic acid | IC50 | 980.0 [1], 2210.0 [2] |
| 2-[[3-[(2-Hydroxyphenyl)methyl]-1,3-diazinan-1-yl]methyl]phenol | IC50 | 500.0 [1] |
| 3-(5-Fluoro-1H-indol-3-yl)-N,N-dimethylpropan-1-amine | IC50 | 49.0 [1], 130.0 [2] |
| 5-Fluoro-N,N-dimethyltryptamine | IC50 | 90.0 [1], 580.0 [2] |
| 7-Fluorotryptamine | IC50 | 28.0 [1], 29.0 [2] |
| 4,6-Dioxa-11-thia-14,15-diazatetracyclo[7.6.0.03,7.010,14]pentadeca-1(15),2,7,9-tetraene | IC50 | 85.0 [1], 87.0 [2] |
| 2-(5-Fluoro-1H-indol-3-yl)-N-methylethanamine | IC50 | 200.0 [1], 650.0 [2] |
| 5-Fluoro-3-(3-(pyrrolidin-1-yl)propyl)-1H-indole | IC50 | 210.0 [1], 320.0 [2] |
| 5-Fluoro-3-[3-(4-phenylpiperazin-1-yl)propyl]-1H-indole | IC50 | 22.0 [1], 60.0 [2] |
| 1H-Indole, 5-fluoro-3-propyl- | IC50 | 100.0 [1] |
| 4-(5-Fluoro-1H-indol-3-yl)-N-methylbutanamide | IC50 | 40.0 [1], 95.0 [2] |
| (5-Fluoro-1H-indol-3-YL)methanamine | IC50 | 900.0 [1], 1000.0 [2] |
| [3-(5-Fluoro-1H-indol-3-yl)propyl]methylamine | IC50 | 26.0 [1], 200.0 [2] |
| 3-(5-Fluoro-1H-indol-3-YL)propylamine | IC50 | 50.0 [1], 650.0 [2] |
| 3-(7-Fluoro-1H-indol-3-yl)propan-1-amine | IC50 | 24.0 [1], 26.0 [2] |
| 5-Fluoro-3-(2-(pyrrolidin-1-yl)ethyl)-1H-indole | IC50 | 40.0 [1], 1030.0 [2] |
| N-Ethyl-N-[(5-fluoro-1H-indol-3-yl)methyl]ethanamine | IC50 | 200.0 [1], 1000.0 [2] |
| 5-Fluoro-3-((4-methylpiperazin-1-yl)methyl)-1H-indole | IC50 | 1000.0 [1] |
| N-Ethyl-2-(5-fluoro-1H-indol-3-yl)ethanamine | IC50 | 300.0 [1], 850.0 [2] |
| N-[2-(5-Fluoro-1H-indol-3-yl)ethyl]propan-1-amine | IC50 | 460.0 [1], 800.0 [2] |
| N-[2-(5-Fluoro-1H-indol-3-yl)ethyl]butan-1-amine | IC50 | 250.0 [1], 1030.0 [2] |
| CID 49856188 | IC50 | 160.0 [1], 510.0 [2] |
| 5-Fluoro-3-(2-(4-methylpiperazin-1-yl)ethyl)-1H-indole | IC50 | 200.0 [1], 650.0 [2] |
| N-Ethyl-3-(5-fluoro-1H-indol-3-yl)propan-1-amine | IC50 | 190.0 [1], 300.0 [2] |
| 3-(5-Fluoro-1H-indol-3-yl)-N-propylpropan-1-amine | IC50 | 170.0 [1], 340.0 [2] |
| N-[3-(5-Fluoro-1H-indol-3-yl)propyl]butan-1-amine | IC50 | 17.0 [1], 1500.0 [2] |
| CID 49856193 | IC50 | 350.0 [1], 390.0 [2] |
| 5-Fluoro-3-(3-(4-methylpiperazin-1-yl)propyl)-1H-indole | IC50 | 310.0 [1], 350.0 [2] |
| 1H-Indole-3-butanenitrile, 5-fluoro- | IC50 | 63.0 [1], 72.0 [2] |
| 5-(5-Fluoro-1H-indol-3-yl)pentanamide | IC50 | 39.0 [1], 43.0 [2] |
| 6-(5-Fluoro-1H-indol-3-yl)hexan-1-amine | IC50 | 260.0 [1], 580.0 [2] |
| 2-[3-(5-Fluoro-1H-indol-3-yl)propylamino]ethanol | IC50 | 10.0 [1], 43.0 [2] |
| 2-[2-(5-Fluoro-1H-indol-3-yl)ethylamino]ethanol | IC50 | 10.0 [1], 31.0 [2] |
| 2-[2-(5-Fluoro-1H-indol-3-yl)ethylsulfanyl]ethanamine | IC50 | 4.0 [1], 8.0 [2] |
| 2-[3-(5-Fluoro-1H-indol-3-yl)propylsulfanyl]ethanamine | IC50 | 21.0 [1], 35.0 [2] |
| 2-[2-(7-Fluoro-1H-indol-3-yl)ethylsulfanyl]ethanamine | IC50 | 3.0 [1], 6.0 [2] |
| 2-[3-(7-Fluoro-1H-indol-3-yl)propylsulfanyl]ethanamine | IC50 | 100.0 [1] |
| 3-(2-(Ethylthio)ethyl)-5-fluoro-1H-indole | IC50 | 100.0 [1] |
| 3-(3-Ethylsulfanylpropyl)-5-fluoro-1H-indole | IC50 | 100.0 [1] |
| N-Ethyl-N-[2-(5-fluoro-1H-indol-3-yl)ethyl]methanesulfonamide | IC50 | 14.0 [1], 27.0 [2] |
| N-Ethyl-N-[3-(5-fluoro-1H-indol-3-yl)propyl]methanesulfonamide | IC50 | 27.0 [1], 37.0 [2] |
| N-[3-(5-Fluoro-1H-indol-3-yl)propyl]hydroxylamine | IC50 | 11.0 [1], 21.0 [2] |
| 5-Fluoro-3-(3-thiocyanatopropyl) 1H-indole | IC50 | 5.0 [1], 23.0 [2] |
| 4-(5-Fluoro-1H-indol-3-yl)butane-1,2-diamine | IC50 | 26.0 [1], 60.0 [2] |
| 3-(7-Fluoro-1H-indol-3-yl)propanamide | IC50 | 64.0 [1], 271.0 [2] |
| 4-(7-Fluoro-1H-indol-3-yl)butanamide | IC50 | 24.0 [1], 26.0 [2] |
| 3-(5-Fluoro-1H-indol-3-yl)propanamide | IC50 | 34.0 [1], 132.0 [2] |
| 5-(7-Fluoro-1H-indol-3-yl)pentanamide | IC50 | 34.0 [1], 44.0 [2] |
| N-Ethyl-4-(5-fluoro-1H-indol-3-yl)butanamide | IC50 | 182.0 [1], 243.0 [2] |
| 1h-Indole-3-butanamine,7-fluoro- | IC50 | 6.0 [1], 21.0 [2] |
| Isoniazid | IC50 | 5000.0 [1] |
| Paroxetine | IC50 | 20.0 [1] |
| Apigenin | IC50 | 3800.0 [1] |
| Kaempferol | IC50 | 2240.0 [1] |
| Nimesulide | IC50 | 2100.0 [1] |
| Flufenamic acid | IC50 | 1800.0 [1] |
| Tryptamine | IC50 | 770.0 [1] |
| Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy-, d- | IC50 | 300.0 [1] |
| o6-Benzylguanine | IC50 | 13000.0 [1] |
| Salicylhydroxamic acid | IC50 | 3000.0 [1] |
| Levosulpiride | IC50 | 7680.0 [1] |
| Nifuroxazide | IC50 | 5000.0 [1] |
| 4-Aminobenzohydrazide | IC50 | 300.0 [1] |
| 7,4'-Dihydroxyflavone | IC50 | 5790.0 [1] |
| N-(4-Methylquinazolin-2-yl)guanidine | IC50 | 900.0 [1] |
| 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide | IC50 | 1900.0 [1] |
| 1,4-Dibenzylpiperazine | IC50 | 10000.0 [1] |
| 3-[2-(Piperidin-1-yl)ethyl]-2-sulfanylquinazolin-4(3H)-one | IC50 | 400.0 [1] |
| 3-[2-(Dimethylamino)ethyl]-2-thioxo-2,3-dihydroquinazolin-4(1H)-one | IC50 | 1700.0 [1] |
| o6-Benzyl-8-oxoguanine | IC50 | 13000.0 [1] |
| 2-[3-(1H-Benzoimidazol-2-yl)-pyridin-2-ylsulfanyl]-1-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethanone | IC50 | 6200.0 [1] |
| 2-[(2E)-2-(1H-Indol-3-ylmethylidene)hydrazinyl]-1H-benzimidazole | IC50 | 12000.0 [1] |
| 3,4-Dihydro-2H-[1,3]oxazino[3,2-b]indazole | IC50 | 359.0 [1] |
| 2-(Piperidin-1-ylmethyl)phenol | IC50 | 10000.0 [1] |
| 3-[2-(Diethylamino)ethyl]-2-sulfanyl-3,4-dihydroquinazolin-4-one | IC50 | 1600.0 [1] |
| 2-Isopropyl-3-methoxy-2H-indazole | IC50 | 704.0 [1] |
| 2-Isopropyl-1,2-dihydroindazol-3-one | IC50 | 660.0 [1] |
| 2-(3-Oxo-1,3-dihydro-2H-indazol-2-yl)propyl acetate | IC50 | 2121.0 [1] |
| 2-Isopropyl-1-(methylsulfonyl)-1H-indazol-3(2H)-one | IC50 | 10000.0 [1] |
| 1-(2-Oxo-2-morpholinoethyl)-2-isopropyl-2,3-dihydro-1H-indazole-3-one | IC50 | 10000.0 [1] |
| 3-Methyl-2,3-dihydro-[1,3]oxazolo[3,2-b]indazole | IC50 | 900.0 [1] |
| 1-Acetyl-2-[1-(acetoxymethyl)ethyl]-2,3-dihydro-1H-indazole-3-one | IC50 | 10000.0 [1] |
| 1-(Methylsulfonyl)-2-[1-(chloromethyl)ethyl]-2,3-dihydro-1H-indazole-3-one | IC50 | 10000.0 [1] |
| 3-Quinolinecarboxylic acid,1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-,(s)- | IC50 | 5000.0 [1] |
| 2-Butyl-1,2-dihydro-3H-indazol-3-one | IC50 | 792.0 [1] |